SIMCERE PHARMAC (Germany) Technical Analysis
S2P Stock | EUR 0.82 0.01 1.20% |
As of the 13th of January 2025, SIMCERE PHARMAC has the risk adjusted performance of 0.0032, and Variance of 8.31. In connection with fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of SIMCERE PHARMAC GRP, as well as the relationship between them. Please validate SIMCERE PHARMAC GRP value at risk, skewness, and the relationship between the maximum drawdown and potential upside to decide if SIMCERE PHARMAC is priced adequately, providing market reflects its prevalent price of 0.82 per share.
SIMCERE PHARMAC Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as SIMCERE, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SIMCERESIMCERE |
SIMCERE PHARMAC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
SIMCERE PHARMAC GRP Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of SIMCERE PHARMAC GRP volatility. High ATR values indicate high volatility, and low values indicate low volatility.
SIMCERE PHARMAC GRP Trend Analysis
Use this graph to draw trend lines for SIMCERE PHARMAC GRP. You can use it to identify possible trend reversals for SIMCERE PHARMAC as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual SIMCERE PHARMAC price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.SIMCERE PHARMAC Best Fit Change Line
The following chart estimates an ordinary least squares regression model for SIMCERE PHARMAC GRP applied against its price change over selected period. The best fit line has a slop of 0 , which means SIMCERE PHARMAC GRP will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.05, which is the sum of squared deviations for the predicted SIMCERE PHARMAC price change compared to its average price change.About SIMCERE PHARMAC Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of SIMCERE PHARMAC GRP on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of SIMCERE PHARMAC GRP based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on SIMCERE PHARMAC GRP price pattern first instead of the macroeconomic environment surrounding SIMCERE PHARMAC GRP. By analyzing SIMCERE PHARMAC's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of SIMCERE PHARMAC's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to SIMCERE PHARMAC specific price patterns or momentum indicators. Please read more on our technical analysis page.
SIMCERE PHARMAC January 13, 2025 Technical Indicators
Most technical analysis of SIMCERE help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for SIMCERE from various momentum indicators to cycle indicators. When you analyze SIMCERE charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.0032 | |||
Market Risk Adjusted Performance | 0.0572 | |||
Mean Deviation | 1.81 | |||
Coefficient Of Variation | (20,922) | |||
Standard Deviation | 2.88 | |||
Variance | 8.31 | |||
Information Ratio | (0) | |||
Jensen Alpha | (0.03) | |||
Total Risk Alpha | 0.0176 | |||
Treynor Ratio | 0.0472 | |||
Maximum Drawdown | 18.98 | |||
Value At Risk | (3.85) | |||
Potential Upside | 2.78 | |||
Skewness | 0.5185 | |||
Kurtosis | 5.58 |
Complementary Tools for SIMCERE Stock analysis
When running SIMCERE PHARMAC's price analysis, check to measure SIMCERE PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SIMCERE PHARMAC is operating at the current time. Most of SIMCERE PHARMAC's value examination focuses on studying past and present price action to predict the probability of SIMCERE PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SIMCERE PHARMAC's price. Additionally, you may evaluate how the addition of SIMCERE PHARMAC to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
CEOs Directory Screen CEOs from public companies around the world | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |